Autonomix Medical (NASDAQ: AMIX), a medical device company, is proceeding with a 1-for-21 reverse stock split of its common stock. As highlighted by GlobeNewswire, this corporate action is scheduled to become effective on June 24, 2026, when the stock will begin trading on a post-split basis.
A reverse stock split is a process where a company reduces its total number of outstanding shares. For Autonomix Medical, every 21 shares will be consolidated into a single share. This action increases the price per share, but the total value of an investor's position is intended to remain the same at the time of the split.
Following the split, Autonomix Medical stock will continue to trade on The Nasdaq Capital Market under the same "AMIX" ticker symbol. However, it will be assigned a new CUSIP number. A CUSIP is a unique code that identifies a security, and a new number is required to reflect the change.
Currently, Autonomix Medical stock is priced at $7.48, with a daily trading range between $6.44 and $7.76. The company has a market capitalization of approximately $4.06 million. Market capitalization represents the total market value of a company's outstanding shares and is calculated by multiplying the share price by the number of shares.
Over the past 52 weeks, the stock has experienced a high of $55.44 and a low of $4.20, indicating significant price movement over the year. The trading volume for the day is 15,813 shares.
